Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07821957 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China

Name: A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China — clinical trial record (NCT07821957)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: APRESENT

StatusRecruiting

PhaseNot applicable

SponsorBeijing Tiantan Hospital

Started2026-01-06

View on ClinicalTrials.gov ↗

Beijing Tiantan Hospital

280 trials monitored

See 4 trials at risk

Intracranial aneurysm, as a common cerebrovascular disease, has a variety of treatment methods, including surgical treatment and endovascular treatment. Among these treatment methods, flow diverters have attracted much attention due to their unique therapeutic principles. Flow diverters help promote thrombus formation within the aneurysm by altering the direction and dynamics of blood flow, thereby achieving the purpose of treatment. 1-5 Flow diverters such as the Pipeline™ device have been proven to be safe and effective for the treatment of intracranial aneurysms and have gradually been recognized as the preferred device for the management of intracranial aneurysms.

Trial Details

NCT Number	NCT07821957
Lead Sponsor	Beijing Tiantan Hospital Collaborators: Huashan Hospital, Peking University International Hospital, Beijing Chao Yang Hospital
Conditions	Intracranial Aneurysm
Enrollment	280 participants
Start Date	2026-01-06
Primary Completion	2030-08-29 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-16